Multi-omics data reveals aberrant gut microbiota-host glycerophospholipid metabolism in association with neuroinflammation in APP/PS1 mice

References

• 2023 Alzheimer’s disease facts and figures. Alzheimer’s & dementia : J Alzheimer’s Assoc. 2023;19(4):1598–18. doi:10.1002/alz.13016.
   Google Scholar
• Susmitha G, Kumar R. Role of microbial dysbiosis in the pathogenesis of Alzheimer’s disease. Neuropharmacology. 2023;229:109478. doi:10.1016/j.neuropharm.2023.109478.
   PubMed Web of Science ®Google Scholar
• Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chételat G, Teunissen CE, Cummings J, van der Flier, WM. Alzheimer’s disease. Lancet. 2021;397:1577–1590. doi:10.1016/S0140-6736(20)32205-4.
   PubMed Web of Science ®Google Scholar
• Qian XH, Song XX, Liu XL, Chen SD, Tang HD. Inflammatory pathways in Alzheimer’s disease mediated by gut microbiota. Ageing Res Rev. 2021;68:101317. doi:10.1016/j.arr.2021.101317.
   PubMed Web of Science ®Google Scholar
• Li B, He Y, Ma J, Huang P, Du J, Cao L, Wang Y, Xiao Q, Tang H, Chen S. Mild cognitive impairment has similar alterations as Alzheimer’s disease in gut microbiota. Alzheimer’s & dementia : J Alzheimer’s Assoc. 2019;15:1357–1366. doi:10.1016/j.jalz.2019.07.002.
   PubMed Web of Science ®Google Scholar
• Borsom EM, Conn K, Keefe CR, Herman C, Orsini GM, Hirsch AH, Palma Avila M, Testo G, Jaramillo SA, Bolyen E, et al. Predicting neurodegenerative disease using prepathology gut microbiota composition: a longitudinal study in mice modeling Alzheimer’s disease pathologies. Microbiol Spectr. 2023;11(2):e0345822. doi:10.1128/spectrum.03458-22.
   PubMed Web of Science ®Google Scholar
• Li Y, Chen Y, Fan Y, Chen Y, Chen Y. Dynamic network modeling of gut microbiota during Alzheimer’s disease progression in mice. Gut Microbes. 2023;15(1):2172672. doi:10.1080/19490976.2023.2172672.
   PubMed Web of Science ®Google Scholar
• Qian XH, Liu XL, Chen G, Chen SD, Tang HD. Injection of amyloid-β to lateral ventricle induces gut microbiota dysbiosis in association with inhibition of cholinergic anti-inflammatory pathways in Alzheimer’s disease. J Neuroinflammation. 2022;19(1):236. doi:10.1186/s12974-022-02599-4.
   PubMed Web of Science ®Google Scholar
• Zhu G, Zhao J, Wang G, Chen W. Bifidobacterium breve HNXY26M4 attenuates cognitive deficits and neuroinflammation by regulating the gut–brain axis in APP/PS1 mice. J Agr Food Chem. 2023;71(11):4646–4655. doi:10.1021/acs.jafc.3c00652.
   PubMed Web of Science ®Google Scholar
• Wang M, Cao J, Gong C, Amakye WK, Yao M, Ren J. Exploring the microbiota-Alzheimer’s disease linkage using short-term antibiotic treatment followed by fecal microbiota transplantation. Brain Behav Immun. 2021;96:227–238. doi:10.1016/j.bbi.2021.06.003.
   PubMed Web of Science ®Google Scholar
• Kim MS, Kim Y, Choi H, Kim W, Park S, Lee D, Kim DK, Kim HJ, Choi H, Hyun D-W, et al. Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer’s disease animal model. Gut. 2020;69(2):283–294. doi:10.1136/gutjnl-2018-317431.
   PubMed Web of Science ®Google Scholar
• Nguyen NM, Cho J, Lee C. Gut microbiota and Alzheimer’s disease: how to study and apply their relationship. Int J Mol Sci. 2023;24(4):24. doi:10.3390/ijms24044047.
   Web of Science ®Google Scholar
• Collins SM, Surette M, Bercik P. The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol. 2012;10(11):735–742. doi:10.1038/nrmicro2876.
   PubMed Web of Science ®Google Scholar
• Feng M, Hou T, Zhou M, Cen Q, Yi T, Bai J, Zeng Y, Liu Q, Zhang C, Zhang Y, et al. Gut microbiota may be involved in Alzheimer’s disease pathology by dysregulating pyrimidine metabolism in APP/PS1 mice. Front Aging Neurosci. 2022;14:967747. doi:10.3389/fnagi.2022.967747.
   PubMed Web of Science ®Google Scholar
• Qian XH, Xie RY, Liu XL, Chen SD, Tang HD. Mechanisms of short-chain fatty acids derived from gut microbiota in Alzheimer’s disease. Aging Dis. 2022;13(4):1252–1266. doi:10.14336/AD.2021.1215.
   PubMed Web of Science ®Google Scholar
• Ge X, Zheng M, Hu M, Fang X, Geng D, Liu S, Wang L, Zhang J, Guan L, Zheng P, et al. Butyrate ameliorates quinolinic acid–induced cognitive decline in obesity models. J Clin Invest. 2023;133(4). doi:10.1172/JCI154612.
   Web of Science ®Google Scholar
• Sun J, Zhang Y, Kong Y, Ye T, Yu Q, Kumaran Satyanarayanan S, Su K-P, Liu J. Microbiota-derived metabolite Indoles induced aryl hydrocarbon receptor activation and inhibited neuroinflammation in APP/PS1 mice. Brain, Behavior, And Immunity. 2022;106:76–88. doi:10.1016/j.bbi.2022.08.003.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Ma X, Wu J, Xiao Z, Wu W, Ding S, Zheng L, Liang X, Luo J, Ding D, et al. Altered gut microbiota and its clinical relevance in mild cognitive impairment and Alzheimer’s disease: Shanghai Aging study and Shanghai memory study. Nutrients. 2022;14(19):14. doi:10.3390/nu14193959.
   Web of Science ®Google Scholar
• Magoč T, Salzberg SL. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinform (Oxford, England). 2011;27(21):2957–2963. doi:10.1093/bioinformatics/btr507.
   PubMed Web of Science ®Google Scholar
• Edgar RC. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods. 2013;10(10):996–998. doi:10.1038/nmeth.2604.
   PubMed Web of Science ®Google Scholar
• Wang Q, Garrity GM, Tiedje JM, Cole JR. Naive bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microb. 2007;73(16):5261–5267. doi:10.1128/AEM.00062-07.
   PubMed Web of Science ®Google Scholar
• Hou YF, Shan C, Zhuang SY, Zhuang QQ, Ghosh A, Zhu KC, Kong X-K, Wang S-M, Gong Y-L, Yang Y-Y, et al. Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson’s disease. Microbiome. 2021;9(1):34. doi:10.1186/s40168-020-00988-6.
   PubMed Web of Science ®Google Scholar
• Hamilton MJ, Weingarden AR, Sadowsky MJ, Khoruts A. Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol. 2012;107(5):761–767. doi:10.1038/ajg.2011.482.
   PubMed Web of Science ®Google Scholar
• Pu Y, Tan Y, Qu Y, Chang L, Wang S, Wei Y, Wang X, Hashimoto K. A role of the subdiaphragmatic vagus nerve in depression-like phenotypes in mice after fecal microbiota transplantation from Chrna7 knock-out mice with depression-like phenotypes. Brain Behav Immun. 2021;94:318–326. doi:10.1016/j.bbi.2020.12.032.
   PubMed Web of Science ®Google Scholar
• Hernández-Chirlaque C, Aranda CJ, Ocón B, Capitán-Cañadas F, Ortega-González M, Carrero JJ, Suárez MD, Zarzuelo A, Sánchez de Medina F, Martínez-Augustin O, et al. Germ-free and antibiotic-treated mice are highly susceptible to epithelial injury in DSS colitis. J Crohn’s Colitis. 2016;10(11):1324–1335. doi:10.1093/ecco-jcc/jjw096.
   Google Scholar
• Zhan G, Yang N, Li S, Huang N, Fang X, Zhang J, Zhu B, Yang L, Yang C, Luo A, et al. Abnormal gut microbiota composition contributes to cognitive dysfunction in SAMP8 mice. Aging. 2018;10(6):1257–1267. doi:10.18632/aging.101464.
   PubMedGoogle Scholar
• Zhao P, Qian X, Nie Y, Sun N, Wang Z, Wu J, Wei C, Ma R, Wang Z, Chai G, et al. Neuropeptide S ameliorates cognitive impairment of APP/PS1 transgenic mice by promoting synaptic plasticity and reducing Aβ deposition. Front Behav Neurosci. 2019;13:138. doi:10.3389/fnbeh.2019.00138.
   PubMed Web of Science ®Google Scholar
• Zhang M, Qian XH, Hu J, Zhang Y, Lin X, Hai W, Shi K, Jiang X, Li Y, Tang H-D, et al. Integrating TSPO PET imaging and transcriptomics to unveil the role of neuroinflammation and amyloid-β deposition in Alzheimer’s disease. Eur J Nucl Med Mol Imaging. 2023;1–13. doi:10.1007/s00259-023-06446-3.
   PubMed Web of Science ®Google Scholar
• Xia J, Psychogios N, Young N, Wishart DS. MetaboAnalyst: a web server for metabolomic data analysis and interpretation. Nucleic Acids Res. 2009;37(Web Server):W652–60. doi:10.1093/nar/gkp356.
   PubMedGoogle Scholar
• Pertea M, Kim D, Pertea GM, Leek JT, Salzberg SL. Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown. Nat Protoc. 2016;11(9):1650–1667. doi:10.1038/nprot.2016.095.
   PubMed Web of Science ®Google Scholar
• Zhu G, Guo M, Zhao J, Zhang H, Wang G, Chen W. Bifidobacterium breve intervention combined with environmental enrichment alleviates cognitive impairment by regulating the gut microbiota and microbial metabolites in Alzheimer’s disease mice. Front Immunol. 2022;13:1013664. doi:10.3389/fimmu.2022.1013664.
   PubMed Web of Science ®Google Scholar
• Bello-Medina PC, Corona-Cervantes K, Zavala Torres NG, González A, Pérez-Morales M, González-Franco DA, Gómez A, García-Mena J, Díaz-Cintra S, Pacheco-López G, et al. Chronic-antibiotics induced gut microbiota dysbiosis rescues memory impairment and reduces β-amyloid aggregation in a preclinical Alzheimer’s disease model. Int J Mol Sci. 2022;23(15):23. doi:10.3390/ijms23158209.
   Web of Science ®Google Scholar
• Nagarajan A, Srivastava H, Morrow CD, Sun LY. Characterizing the gut microbiome changes with aging in a novel Alzheimer’s disease rat model. Aging. 2023;15(2):459–471. doi:10.18632/aging.204484.
   PubMedGoogle Scholar
• Kaiyrlykyzy A, Kozhakhmetov S, Babenko D, Zholdasbekova G, Alzhanova D, Olzhayev F, Baibulatova A, Kushugulova, AR, Askarova S. Study of gut microbiota alterations in Alzheimer’s dementia patients from Kazakhstan. Sci Rep. 2022;12:15115. doi:10.1038/s41598-022-19393-0.
   PubMed Web of Science ®Google Scholar
• Jung JH, Kim G, Byun MS, Lee JH, Yi D, Park H, Lee DY. Gut microbiome alterations in preclinical Alzheimer’s disease. PloS One. 2022;17(11):e0278276. doi:10.1371/journal.pone.0278276.
   PubMed Web of Science ®Google Scholar
• Wang SS, Li XH, Liu P, Li J, Liu L. The relationship between Alzheimer’s disease and intestinal microflora structure and inflammatory factors. Front Aging Neurosci. 2022;14:972982. doi:10.3389/fnagi.2022.972982.
   PubMed Web of Science ®Google Scholar
• Dunham SJB, McNair KA, Adams ED, Avelar-Barragan J, Forner S, Mapstone M, Whiteson KL. Longitudinal analysis of the microbiome and metabolome in the 5xfAD mouse model of Alzheimer’s disease. mBio. 2022;13(6):e0179422. doi:10.1128/mbio.01794-22.
   PubMed Web of Science ®Google Scholar
• Javed I, Zhang Z, Adamcik J, Andrikopoulos N, Li Y, Otzen DE, Lin S, Mezzenga R, Davis TP, Ding F, et al. Accelerated amyloid beta pathogenesis by bacterial amyloid FapC. Adv Sci (Weinheim, Baden-Wurttemberg, Germany). 2020;7(18):2001299. doi:10.1002/advs.202001299.
   PubMedGoogle Scholar
• Choi CS, Gwin M, Voth S, Kolb C, Zhou C, Nelson AR, deWeever A, Koloteva A, Annamdevula NS, Murphy JM, et al. Cytotoxic tau released from lung microvascular endothelial cells upon infection with Pseudomonas aeruginosa promotes neuronal tauopathy. J Biol Chem. 2022;298(1):101482. doi:10.1016/j.jbc.2021.101482.
   PubMed Web of Science ®Google Scholar
• Guido ME, Monjes NM, Wagner PM, Salvador GA. Circadian regulation and clock-controlled mechanisms of glycerophospholipid metabolism from neuronal cells and tissues to fibroblasts. Mol Neurobiol. 2022;59(1):326–353. doi:10.1007/s12035-021-02595-4.
   PubMed Web of Science ®Google Scholar
• Kim SJ, Tang T, Abbott M, Viscarra JA, Wang Y, Sul HS. AMPK phosphorylates Desnutrin/ATGL and hormone-sensitive lipase to regulate lipolysis and fatty acid oxidation within adipose tissue. Mol Cell Biol. 2016;36(14):1961–1976. doi:10.1128/MCB.00244-16.
   PubMed Web of Science ®Google Scholar
• Fiume R, Faenza I, Sheth B, Poli A, Vidalle MC, Mazzetti C, Abdul SH, Campagnoli F, Fabbrini M, Kimber ST, et al. Nuclear phosphoinositides: Their regulation and roles in nuclear functions. Int J Mol Sci. 2019;20(12):20. doi:10.3390/ijms20122991.
   Web of Science ®Google Scholar
• Zheng P, Wu J, Zhang H, Perry SW, Yin B, Tan X, Chai T, Liang W, Huang Y, Li Y, et al. The gut microbiome modulates gut–brain axis glycerophospholipid metabolism in a region-specific manner in a nonhuman primate model of depression. Mol Psychiatr. 2021;26(6):2380–2392. doi:10.1038/s41380-020-0744-2.
   PubMed Web of Science ®Google Scholar
• Tian T, Mao Q, Xie J, Wang Y, Shao WH, Zhong Q, Chen J-J. Multi-omics data reveals the disturbance of glycerophospholipid metabolism caused by disordered gut microbiota in depressed mice. J Adv Res. 2022;39:135–145. doi:10.1016/j.jare.2021.10.002.
   PubMed Web of Science ®Google Scholar
• Xie J, Zhong Q, Wu WT, Chen JJ. Multi-omics data reveals the important role of glycerophospholipid metabolism in the crosstalk between gut and brain in depression. J Transl Med. 2023;21(1):93. doi:10.1186/s12967-023-03942-w.
   PubMed Web of Science ®Google Scholar
• Zhang X, Wu C, Tan W. Brain lipid dynamics in amyloid precursor Protein/presenilin 1 mouse model of early alzheimer’s disease by desorption electrospray ionization and matrix assisted laser desorption ionization–mass spectrometry imaging techniques. J Proteome Res. 2021;20(5):2643–2650. doi:10.1021/acs.jproteome.0c01050.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Chen H, Iqbal J, Liu X, Zhang H, Xiao S, Jin N, Yao F, Shen L. Targeted metabolomics study of early pathological features in hippocampus of triple transgenic Alzheimer’s disease male mice. J Neurosci Res. 2021;99(3):927–946. doi:10.1002/jnr.24750.
   PubMed Web of Science ®Google Scholar
• Qian XH, Liu XL, Chen SD, Tang HD. Identification of immune hub genes associated with braak stages in Alzheimer’s disease and their correlation of immune infiltration. Front Aging Neurosci. 2022;14:887168. doi:10.3389/fnagi.2022.887168.
   PubMed Web of Science ®Google Scholar
• Qian XH, Liu XL, Chen SD, Tang HD. Integrating peripheral blood and brain transcriptomics to identify immunological features associated with Alzheimer’s disease in mild cognitive impairment patients. Front Immunol. 2022;13:986346. doi:10.3389/fimmu.2022.986346.
   PubMed Web of Science ®Google Scholar
• Thakur S, Dhapola R, Sarma P, Medhi B, Reddy DH. Neuroinflammation in Alzheimer’s disease: Current progress in molecular signaling and therapeutics. Inflammation. 2023;46(1):1–17. doi:10.1007/s10753-022-01721-1.
   PubMed Web of Science ®Google Scholar
• Thu Thuy Nguyen V, Endres K. Targeting gut microbiota to alleviate neuroinflammation in Alzheimer’s disease. Adv Drug Deliv Rev. 2022;188:114418. doi:10.1016/j.addr.2022.114418.
   PubMed Web of Science ®Google Scholar
• Zhou R, Qian S, Cho WCS, Zhou J, Jin C, Zhong Y, Wang J, Zhang X, Xu Z, Tian M, et al. Microbiota-microglia connections in age-related cognition decline. Aging Cell. 2022;21(5):e13599. doi:10.1111/acel.13599.
   PubMed Web of Science ®Google Scholar
• Bairamian D, Sha S, Rolhion N, Sokol H, Dorothée G, Lemere CA, Krantic S. Microbiota in neuroinflammation and synaptic dysfunction: a focus on Alzheimer’s disease. Mol Neurodegener. 2022;17(1):19. doi:10.1186/s13024-022-00522-2.
   PubMed Web of Science ®Google Scholar
• Huang Y, Wu J, Zhang H, Li Y, Wen L, Tan X, Cheng K, Liu Y, Pu J, Liu L, et al. The gut microbiome modulates the transformation of microglial subtypes. Mol Psychiatr. 2023;28(4):1611–1621. doi:10.1038/s41380-023-02017-y.
   PubMed Web of Science ®Google Scholar
• Pietzner M, Kaul A, Henning AK, Kastenmüller G, Artati A, Lerch MM, Adamski J, Nauck M, Friedrich N. Comprehensive metabolic profiling of chronic low-grade inflammation among generally healthy individuals. BMC Med. 2017;15(1):210. doi:10.1186/s12916-017-0974-6.
   PubMed Web of Science ®Google Scholar
• Yu EA, He S, Jones DP, Sun YV, Ramirez-Zea M, Stein AD. Metabolomic profiling demonstrates postprandial changes in fatty acids and glycerophospholipids are associated with fasting inflammation in Guatemalan adults. J Nutr. 2021;151(9):2564–2573. doi:10.1093/jn/nxab183.
   PubMed Web of Science ®Google Scholar
• Su D, Liao L, Zeng Q, Liao Z, Liu Y, Jin C, Zhu G, Chen C, Yang M, Ai Z, et al. Study on the new anti-atherosclerosis activity of different herba patriniae through down-regulating lysophosphatidylcholine of the glycerophospholipid metabolism pathway. Phytomed: Inter J Phytothera And Phytopharmacol. 2022;94:153833. doi:10.1016/j.phymed.2021.153833.
   PubMed Web of Science ®Google Scholar
• Webster SJ, Bachstetter AD, Nelson PT, Schmitt FA, Van Eldik LJ. Using mice to model Alzheimer’s dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models. Front Genet. 2014;5:88. doi:10.3389/fgene.2014.00088.
   PubMed Web of Science ®Google Scholar
• Kosel F, Pelley JMS, Franklin TB. Behavioural and psychological symptoms of dementia in mouse models of Alzheimer’s disease-related pathology. Neurosci Biobehav Rev. 2020;112:634–647. doi:10.1016/j.neubiorev.2020.02.012.
   PubMed Web of Science ®Google Scholar